Legend Biotech.
Biotech company
- Reports this week
- 1
- Active events
- 0
- Connections
- 29
What's happening
One to three months ago
-
Analysts view Legend Biotech's current valuations as a buying opportunity.Speculative1 report1 development inside
-
Royal Bank of Canada cut its price target on Legend Biotech in a research report.Some support2 reports
-
Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.Some support3 reports
-
Legend Biotech and Janssen Biotech announced a partnership on January 22, 2026, to advance cell therapy treatments. The companies are headquartered in Somerset, New Jersey.Some support1 report
-
Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.Well supported5 reports
Gone quiet
No new reports in 90+ days-
Micron Technology, AAON, Legend Biotech, and Franco-Nevada saw stock movements on August 12, 2025, following earnings reports, including surges, plunges, and rises.Some support1 report
-
Legend Biotech reported record CARVYKTI sales driving revenue growth, coinciding with an FDA label update to reduce monitoring.Some support1 report
-
Legend Biotech reported a Q2 beat, indicating strong demand and successful manufacturing.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Legend Biotech this week
News at the entities that move Legend Biotech most-
Johnson & Johnson StructuralP&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Moves Legend Biotech
-
Novartis StructuralNovartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Moves Legend Biotech
-
Morgan Stanley Mentioned togetherFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves Legend Biotech
-
LinkedIn OperationalBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves Legend Biotech
-
Janssen Biotech OperationalJ&J and Janssen Biotech jointly won summary judgment in a Virginia court regarding J&J's acquisition, with FTC filing an amicus brief.Moves Legend Biotech
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Legend Biotech
Connections
The 14 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Johnson & Johnson Structural
Legend Biotech and Johnson & Johnson maintain a deep structural partnership, co-developing and supplying the CARVYKTI treatment, cemented by J&J's investment in Legend's portfolio.
-
Ying Huang Structural
Ying Huang served as the Chief Executive Officer and Board member of Legend Biotech.
-
CAR Structural
The company's existence is fundamentally tied to the single CAR-T franchise technology.
-
Janssen Biotech Operational
Legend Biotech and Janssen Biotech are partnering to advance cell therapy treatments.
-
Novartis Structural
Legend Biotech leverages expertise and talent pools from Novartis, indicating a functional dependency on Novartis's ecosystem.
-
Carlos Santos Structural
Carlos Santos serves as the Chief Financial Officer of Legend Biotech.
-
Nasdaq Structural
Legend Biotech is formally listed and trades on the Nasdaq stock exchange, establishing a market dependency.
-
LinkedIn Operational
Legend Biotech utilizes LinkedIn as a platform for maintaining its professional presence.
Show all 14 connections
-
New Jersey Shared context
Legend Biotech is headquartered in Somerset, New Jersey.
-
Janssen Operational
The relationship is defined by a collaboration agreement that drives higher sales for Legend Biotech.
-
Royal Bank of Canada Mentioned together
Legend Biotech is the subject of financial analysis and valuation reports from the investment banking sector represented by Royal Bank of Canada.
-
AbbVie Mentioned together
Both entities are cited as major players operating within the competitive pharmaceutical sector.
-
Morgan Stanley Mentioned together
Morgan Stanley provides investment coverage, including target price and rating changes, for Legend Biotech.
-
Ireland Shared context
Legend Biotech is expanding its market presence and launching products in Ireland.
History
Events by the month they beganAugust 2026
3 events- Royal Bank of Canada cut its price target on Legend Biotech in a research report.
- Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.
- Legend Biotech and Janssen Biotech announced a partnership on January 22, 2026, to advance cell therapy treatments. The companies are headquartered in Somerset, New Jersey.
June 2026
6 events- Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.
- Analysts view Legend Biotech's current valuations as a buying opportunity.
- Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.
- Micron Technology, AAON, Legend Biotech, and Franco-Nevada saw stock movements on August 12, 2025, following earnings reports, including surges, plunges, and rises.
- Legend Biotech reported record CARVYKTI sales driving revenue growth, coinciding with an FDA label update to reduce monitoring.
- Legend Biotech reported a Q2 beat, indicating strong demand and successful manufacturing.